In this episode, Fred Turner, CEO of Curative, shares the journey of scaling the company from a COVID-19 testing powerhouse to a disruptive force in the commercial health plan space. He discusses Curative’s unique no-deductible model, the importance of early patient engagement, and the challenges of entering a highly regulated industry dominated by a few major players.
Fred Turner, CEO of Curative
Advertisement
Advertisement
Next Up in Becker’s Payer Issues Podcast
-
In this episode, Joseph Ng MD, MBA, Medical Director, Mather Hospital Northwell Health, President of Mather Medical Group, Critical Care…
-
In this episode, Tanner White, MBA, FACHE, Chief Executive Officer at Altru Devils Lake, joins the podcast to discuss the…
-
In this episode, Dr. Scott Law, Co-Founder of Smile Doctors, joins the podcast to discuss Smile Express, remote monitoring and…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
Advertisement
Comments are closed.